[ET Net News Agency, 23 April 2024] KEYMED BIO-B (02162) rose 10.5% to HK$32.2,
breaking above the 20-D SMA of HK$31.39.
It hits an intra-day high of HK$32.2, and an intra-day low of HK$29.95. The total shares
traded was 463,500, with a value of HK$14.25m. The active buy/sell ratio is 56:44, with
net buying turnover of HK$1.53m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$714,372, with volume weighted average price of HK$30.503.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$1.84m, with
volume weighted average price of HK$30.837. The stock has risen a combined 17.3% over the
past 2 consecutive trading days.

Basic Information
=================

-----------------------------------
Nominal 32.200 % Chg +10.46%
High 32.200 Low 29.950
Shares Tr 463,500 Turnover 14.25m
10-D SMA 30.625 %H.V 65.971
20-D SMA 31.390 VWAP 30.742
50-D SMA 33.076 RSI14 50.489
-----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 56:44, with net buying
turnover of HK$1.53m, rising a combined 17.3% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
KEYMED BIO-B (02162) 32.20 +10.46
HUTCHMED (00013) 28.05 +4.28
GENSCRIPT BIO (01548) 10.98 -0.36
INNOVENT BIO (01801) 35.65 +5.01
EVEREST MED-B (01952) 23.80 +1.93
LAEKNA-B (02105) 6.29 +17.79
WUXI XDC (02268) 20.20 +7.79
WUXI BIO (02269) 13.02 +1.72
BEIGENE (06160) 81.65 +2.51
AKESO (09926) 46.40 +4.62
---------------------------------------------
(ed)